Rachel J Tyson - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Frontiers in Pharmacology|May 12, 2020

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.

American Heart Journal|January 26, 2021

Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbiditiesNancy M Albert, Rachel J Tyson, C Larry Hill, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Frontiers in Pharmacology|May 12, 2020

Precision Dosing Priority Criteria: Drug, Disease, and Patient Population VariablesRachel J Tyson, Christine C Park, J Robert Powell, et al.

American Heart Journal|January 26, 2021

Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbiditiesNancy M Albert, Rachel J Tyson, C Larry Hill, et al.

Pageof 1